Delivery Order SPE2DU25D9415-SPE2DU26FEHYP
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $1,579.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. This delivery order, awarded on October 21, 2025, with an ultimate completion date of October 23, 2025, utilizes a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group was selected as a...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, represents one of numerous awards made to DMS Pharmaceutical Group under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $56,604.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 21, 2025, is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V is a $30.3 billion...
- The Defense Logistics Agency issued a delivery order valued at $1,882.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. This delivery order, issued on October 19, 2025, with an ultimate completion date of October 20, 2025, represents a firm fixed-price purchase with no set-aside designation, reflecting the contractor's competitive...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $113,749.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, carries no set-aside designation, indicating the contractor competed in an unrestricted federal procurement environment. DMS Pharmaceutical Group is...
- The Defense Logistics Agency issued a $7,481.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, awarded on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a component of DMS Pharmaceutical Group's broader engagement as a regional prime vendor under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 27, 2025, represents a firm fixed-price procurement with an ultimate completion date of October 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $7,466.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents one of numerous recent purchases from the vendor without set-aside designation. The award falls under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency awarded a $3,986.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 22, 2025, represents a single transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The award carries no set-aside...
- The Defense Logistics Agency awarded a $8,727 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 22, 2025, with an ultimate completion date of October 30, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DU25D9415Indefinite Delivery Contract
- SPE2DU25D9415-SPE2DU26FEHYPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,532.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on October 22, 2025. This firm fixed-price delivery order represents one of numerous orders issued to the vendor under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion Defense Logistics Agency acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense medical facilities worldwide. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. Performance will take place at the vendor's Park Ridge, Illinois location, with an ultimate completion date of October 23, 2025. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under the PPV-G GEN V initiative with a $499,999,999 ceiling value extending through December 31, 2036, positioning the company as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceuticals and medical consumables. The vendor's product portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals to support the full spectrum of military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.5k | 10/22/25 |